At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 23 enrolled
Drug / intervention
Cisplatin +1 moredrug
Likely dose
Cisplatin 75mg/m2from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II of Radiochemotherapy in Elderly Patients With Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon·interventional·Posted Aug 25, 2016·Updated Aug 25, 2016
In Brief
A Phase 2 clinical trial evaluating Cisplatin and Oxaliplatin for Esophagus Cancer. Completed, enrolled 23 participants.
Detailed Summary
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophagus Cancer
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
Primary CompletionDec 2014
First PostedAug 2016
TodayJul 2026
First PostedAug 25, 2016
Enrollment StartJan 1, 2010
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 9.9 years ago
Interventions
Cisplatindrug
Arm cisplatin : 75mg/m2, day n\*1 and day n\*22, And radiotherapy 50 Gy, 2Gy/f
Oxaliplatindrug
85 mg/m2 every 2 weeks, 6 times And radiotherapy 50 Gy, 2Gy/f